In the past 52-week period, shares of Auris Medical Holding AG (NASDAQ:EARS) have moved within the range of $0.38 to $1.39. On the stock’s most recent trading day, the company’s shares ended the regular session at $0.53, which is 61.87% higher than its 52-week high.
Auris Medical Holding AG (EARS) has demonstrated a 20-day simple moving average (SMA) of 10.81%, and a 50-day SMA of -14.56%. This public company’s current market capitalization stands at $25.56 million.Analyzing Consensus Estimates, Sales Revenue and Net Income
Gauging the level of enthusiasm that Wall Street analysts have for a particular stock is important when considering an investment. According to the latest data, the consensus recommendation for Auris Medical Holding AG (EARS) is Outperform.
When it comes to reporting sales figures, public companies typically post earnings and revenue that fall above or below the average Wall Street forecast. In the most recent quarterly financial report, for the quarter ending Jun. 2017, Auris Medical Holding AG (EARS) delivered a 0.00% surprise with its net revenue.Ownership at Auris Medical Holding AG (EARS), According to Most Recent SEC Filings
A publicly-traded company’s most recent 13F filings give us important details about the organization’s institutional ownership. Auris Medical Holding AG (EARS) has 0 billion shares outstanding currently, 25.17% of which belong to institutional investors. Those institutional holdings amount to $0.01 billion.
Additionally, according to the most recent 13F filing from Auris Medical Holding AG (EARS), there were 1 new positions totaling 12,326 shares of the company’s stock. There were 7 sold out positions, on the other hand, totaling 1,164,425 shares.Short, Medium and Long Term Indicators
Taking a look at a stock’s average volume – in the long, medium and short terms – is helpful for understanding investor sentiment and trading activity. Auris Medical Holding AG (EARS) has had a 20-day average volume of 1,611,290 shares, with an average of 20% of short term indicators pointed at Buy.
The stock’s 50-day average volume has been 1,340,732 shares, with an average of 75% of medium term indicators pointing toward Sell. Finally, its 100-day average volume is 865,180 shares with 67% of long-term indicators pointing to Sell.